T
he efficacy of intermittent chemotherapy for pulmonary tuberculosis has been well d~c u m e n t e d . '~~ There are no reports which consider the efficacy of this regimen in extrapulmonary tuberculosis, although a recent report by Hudson and Sbarbaroa of patients treated with twice-weekly therapy included four patients with extrapulmonary tuberculosis (three with lymph node *From the USPHS Indian Hospital, Whiteriver, Ariz. Reprint requests: Dr. Cyomon, 40 North Kingshighway Blvd., St. h i s 63108 and one with peritoneal). In contrast to the situation with pulmonary tuberculosis, patients with extrapulmonary involvement do not usually present a serious infectious threat to the community. The treatment of either type of infection is generally similar, consisting of administration of two or three drugs for a period of 18 to 24 months.' If longterm therapy is not taken regularly and for an adequate period, relapse often occurs, frequently with the emergence of drug resistant organisms. The difficulties with self-administered chemotherapy in pulmonary tuberculosis are thoughtfully reviewed by FOX.^ Intermittent supervised therapy for pulmonary tuberculosis equals the effectiveness of the best daily inpatient regimen; exceeds daily unsupervised outpatient regimens; avoids the irregularity of self-administered oral regimens due to greater supervision; and has a lower rate of adverse reactions because of the lower total weekly dose of intermittently administered drugs.'
The patients discussed in this report include all patients with culture-proved extrapulmonary tuberculosis treated at the USPHS Whiteriver Indian Hospital on the Fort Apache Indian Reservation as part of an intermittent ambulatory chemotherapy program.6 The patients were hospitalized locally or at a contract sanatorium for diagnosis and for the initial of treatment. Initial therapy consisted of daily isoniazid ( INH ) , streptomycin ( SM ) , and either paraaminosalicylic acid (PAS) or ethambutol (EMB). All patients were discharged to their reservation homes for outpatient intermittent therapy; no treatment options were given. They attended clinic twice-weekly for the medications-INH ( 15 mg/kg), SM (24 mg/kg), and pyridoxine (50 mg) for the duration of the treatment period. Patients were evaluated monthly by a physician in chest clinic during the &st year and then, every three months during the second year. *Regimen consisted of routine doses of isoniaeid, paraaminosalicylic acid and streptomycin. tIeoniazid (15 =/kg), pyridoxine (50 mg) and streptomycin (24 mg/kg) administered twice-weekly. **Ethambutol was used during this period instead of paraaminosslicylic acid. ttEthambuto1 (15 rng/kg/day) was used for 9 months.
Between January, 1970 and July, 1973, seven Indians with extrapulmonary tuberculosis completed therapy. The data are summarized in Tables 1 and 2. The types of extrapulmonary tuberculosis included cervical lymphadenitis, peritonitis, genitourinary tuberculosis, perirectal abscess, and miliary tuberculosis. All of the patients had positive skin tests (greater than 10 mm) with 5 tuberculin units of purified protein derivative (six tested at the time of diagnosis, the other one, previously known to be positive and not retested). All of the patients had positive cultures for Mycobacterium tuberculosis which were sensitive to the primary antituberculosis medications. It was clinically feasible to obtain serial cultures in only three of the patients (cases 3, 4 and 7 ) . Positive cultures for case 3 (sputum and lymph node) and case 7 (urine) were obtained initially; however, subsequent cultures were negative. Case 4 had a positive urine culture initially; the last positive culture occurred during the fourth month of therapy.
The length of daily therapy averaged 3.3 months (range 1-7 months). The duration of intermittent therapy was 19.6 months (range 16-23 months). Total period of treatment ( including daily therapy) averaged 22.9 months ( range 17-24 months). The rate of missed appointments was 7.3 percent ( range 1-12 percent) .
Duration of follow-up after completion of the drug regimen ranged from 6-21 months (mean 14 months). All the patients remained free of evidence of tuberculosis during this period. The intermittent therapy was well tolerated, and no adverse reactions were noted. However, a significant rate of adverse reactions due to SM has been observed by others.3
Although the experience has been limited, the authors feel that intermittent supervised chemotherapy is an effective alternative to daily self-administered medication in the treatment of extrapulmonary tuberculosis. It increases the likelihood of completing an adequate outpatient course of therapy, particularly in patients with socio-economic and alcohol-related problems and in those who are unable to understand and accept their disease. The long periods of initial daily therapy in the present report were due to the previous practice of hospitalizing the patients (cases 1,2,4 and 7 ) at contract tuberculosis sanitoria. Currently, patients with tuberculosis (pulmonary or extrapulmonary) are treated initially with a short period of daily therapy (inpatient or outpatient, depending on the indications for hospitalization) and, then, receive intermittent therapy for the duration of the treatment ~eriod.
The authors feel that adequate therapy for most cases of extrapulmonary tuberculosis includes an initial period of daily therapy (1-2 months) 
